NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 56 filers reported holding NEOS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $15,000 | +15.4% | 24,995 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $13,000 | -23.5% | 24,995 | 0.0% | 0.01% | -27.3% |
| Q2 2020 | $17,000 | -5.6% | 24,995 | 0.0% | 0.01% | -21.4% |
| Q1 2020 | $18,000 | -100.0% | 24,995 | 0.0% | 0.01% | -33.3% |
| Q4 2019 | $37,742,000 | +110905.9% | 24,995 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $34,000 | +3.0% | 24,995 | 0.0% | 0.02% | +10.5% |
| Q2 2019 | $33,000 | -47.6% | 24,995 | 0.0% | 0.02% | -47.2% |
| Q1 2019 | $63,000 | +53.7% | 24,995 | 0.0% | 0.04% | +33.3% |
| Q4 2018 | $41,000 | – | 24,995 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|